| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136723 Administering methotrexate and an anti-tumor necrosis factor antibody or fragment thereof; rheumatoid arthritis, Crohn's disease, acute and chronic immune diseases |
| 09/26/2002 | US20020136720 Methods of using IMXP-888 and IMXP-888 antagonists |
| 09/26/2002 | US20020136701 Applying to area of body having ectoparasites a composition comprising non-volatile surfactants, polar organic compounds, non-volatile fatty alcohols, and non-volatile fatty esters, for a time sufficient to trigger immersion reflex, drying |
| 09/26/2002 | US20020136697 4-hydroxyisothiazole compounds |
| 09/26/2002 | US20020136689 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds |
| 09/26/2002 | US20020135085 Production scale method of forming microparticles |
| 09/26/2002 | DE10114305A1 Reducing sebum production using cosmetic or dermatological preparations containing isoflavones, useful for e.g. eliminating comedones or treating greasy hair or dandruff |
| 09/26/2002 | DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors |
| 09/26/2002 | DE10113366A1 Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
| 09/26/2002 | DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections |
| 09/26/2002 | DE10112041A1 p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate p-thienylbenzyl amides as agonists of angiotensin- (1-7) receptors, processes for their preparation, their use and pharmaceutical compositions containing them |
| 09/26/2002 | DE10110391A1 Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff Highly flexible nicotine transdermal therapeutic system with nicotine as a drug |
| 09/26/2002 | CA2758923A1 Use of tramadol to delay ejaculation |
| 09/26/2002 | CA2448795A1 Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent |
| 09/26/2002 | CA2445374A1 Process for producing lactic acid oligomer |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2442717A1 Methods for restoring cognitive function following systemic stress |
| 09/26/2002 | CA2442268A1 Benzimidazol derivatives modulate chemokine receptors |
| 09/26/2002 | CA2442000A1 Pharmaceutical composition for the treatment of diabetes comprising a 5-phenoxyalkal-2,4-thiazolidinedione derivative and a compound that stimulates insulin secretion |
| 09/26/2002 | CA2441822A1 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/26/2002 | CA2441616A1 Composition comprising cocoa and a dopamine d2 receptor agonist |
| 09/26/2002 | CA2441563A1 Allosteric adenosine receptor modulators |
| 09/26/2002 | CA2441536A1 Polybutene containing chewing gum and confection |
| 09/26/2002 | CA2441503A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | CA2441428A1 Highly purified and crystalline form of harringtonine |
| 09/26/2002 | CA2441427A1 Biurethane derivatives |
| 09/26/2002 | CA2441425A1 Antipruritics |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441289A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 09/26/2002 | CA2441202A1 Chemical compounds |
| 09/26/2002 | CA2441162A1 Pharmaceutical composition comprising, as an active ingredient, triazaspiro[5.5]undecane derivative |
| 09/26/2002 | CA2441155A1 Methods of treating respiratory conditions |
| 09/26/2002 | CA2441152A1 Hormone replacement therapy |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/26/2002 | CA2441064A1 Controlled release sulfonylurea formulation |
| 09/26/2002 | CA2441016A1 Taurine compounds |
| 09/26/2002 | CA2440954A1 Phenyl derivatives 3 |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2440687A1 Dermatological preparations |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440482A1 Tryptase-inhibitors |
| 09/26/2002 | CA2440480A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440391A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
| 09/26/2002 | CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 09/26/2002 | CA2440261A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 09/26/2002 | CA2440106A1 Substituted benzopyranones as telomerase inhibitors |
| 09/26/2002 | CA2440002A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 09/26/2002 | CA2439952A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2439528A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors |
| 09/26/2002 | CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | CA2435825A1 New composition |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2434030A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 09/26/2002 | CA2430619A1 Farnesyltransferase inhibitors |
| 09/26/2002 | CA2404701A1 Triazole compounds having amide linkage |
| 09/26/2002 | CA2404581A1 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/26/2002 | CA2404422A1 Preparations for preventing bile acid diarrhea |
| 09/26/2002 | CA2404381A1 Oily compositions containing highly fat-soluble drugs |
| 09/26/2002 | CA2403903A1 Angiogenesis inhibitors |
| 09/25/2002 | WO2001074354A1 DIURETICS CONTAINING η-TOCOTRIENOL |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243586A1 Phloridzin-rich phenolic fraction and its use as cosmetic, food or nutritional agent |
| 09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
| 09/25/2002 | EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243290A2 Modulation of gene expression by combination therapy |
| 09/25/2002 | EP1243276A1 Elongated and multiple spacers containing activatible prodrugs |
| 09/25/2002 | EP1243273A1 Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| 09/25/2002 | EP1243272A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 09/25/2002 | EP1243271A1 Nasal drops containing fused pyridazine derivatives |
| 09/25/2002 | EP1243270A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 09/25/2002 | EP1243269A2 Opioid formulations having extended controlled release |
| 09/25/2002 | EP1243268A1 Medicinal composition |
| 09/25/2002 | EP1243267A2 Amoxycillin and clavulanate containing pharmaceutical formulation |
| 09/25/2002 | EP1243266A1 Solid preparations for oral use |
| 09/25/2002 | EP1243264A2 Inhibition of nitric oxide production by retinoic acid |
| 09/25/2002 | EP1243263A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 09/25/2002 | EP1243262A1 Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
| 09/25/2002 | EP1243261A1 Use of a hydantoin derivative in a pharmaceutical composition against hypoalbuminaemia |
| 09/25/2002 | EP1243259A1 Sustained release preparation comprising one or more antibiotics and polymers |
| 09/25/2002 | EP1243258A1 Production of a preparation comprising one or more antibiotics |
| 09/25/2002 | EP1243257A1 Sustained release preparation comprising one or more antibiotics |
| 09/25/2002 | EP1243255A2 Method of preparation of antibiotic compositions |
| 09/25/2002 | EP1243252A1 Skin composition containing fibres and ubiquinones |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242587A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242445A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 09/25/2002 | EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 09/25/2002 | EP1242437A2 Novel stromelysin inhibitors |